177 related articles for article (PubMed ID: 15690761)
1. Comparative inhibition of inducible and constitutive CYPs in rat hepatic microsomes by parathion.
Murray M; Butler AM
Xenobiotica; 2004 Aug; 34(8):723-39. PubMed ID: 15690761
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
4. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
Chung WG; Roh HK; Kim HM; Cha YN
Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
[TBL] [Abstract][Full Text] [Related]
6. Reversible and time-dependent inhibition of the hepatic cytochrome P450 steroidal hydroxylases by the proestrogenic pesticide methoxychlor in rat and human.
Li HC; Mani C; Kupfer D
J Biochem Toxicol; 1993 Dec; 8(4):195-206. PubMed ID: 8114062
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
8. Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver.
Fabrizi L; Gemma S; Testai E; Vittozzi L
J Biochem Mol Toxicol; 1999; 13(1):53-61. PubMed ID: 9890448
[TBL] [Abstract][Full Text] [Related]
9. Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and metyrapone.
Murray M; Sefton RM; Martini R; Butler AM
Chem Biol Interact; 1998 Jun; 113(3):161-73. PubMed ID: 9717516
[TBL] [Abstract][Full Text] [Related]
10. Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats.
Hurh E; Lee E; Lee A; Kim Y; Kim S; Kim S; Lee M
Biopharm Drug Dispos; 2000 Jul; 21(5):193-204. PubMed ID: 11180198
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
12. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
13. Pretranslational and posttranslational regulation of rat hepatic CYPs 3A2 and 2E1 by disulfiram.
Martini R; Ingelman-Sundberg M; Murray M
Biochem Pharmacol; 1997 Dec; 54(12):1323-9. PubMed ID: 9393675
[TBL] [Abstract][Full Text] [Related]
14. Metabolite-intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem.
Trieu L; Murray M
Xenobiotica; 2000 Feb; 30(2):131-40. PubMed ID: 10718121
[TBL] [Abstract][Full Text] [Related]
15. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of rat hepatic microsomal cytochromes P-450 in microvesicular steatosis induced by orotic acid.
Su GM; Sefton RM; Murray M
J Pharmacol Exp Ther; 1999 Dec; 291(3):953-9. PubMed ID: 10565810
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily.
Ciaccio PJ; Halpert JR
Arch Biochem Biophys; 1989 Jun; 271(2):284-99. PubMed ID: 2786372
[TBL] [Abstract][Full Text] [Related]
19. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
20. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms.
Rosenbrock H; Hagemeyer CE; Singeç I; Knoth R; Volk B
J Neuroendocrinol; 1999 Aug; 11(8):597-604. PubMed ID: 10447797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
